This is in contrast to observations in head and neck squamous cell carcinoma (HNSCC), where TA-MSCs display reduced levels of CD39 and CD73 compared to NTA-MSCs [34]. This evidence concerns the gene NT5E and head and neck squamous cell carcinoma.